STAT3 and neoplasm: STAT3 signaling is involved in a variety of intrinsic and acquired resistance mechanisms to administered anti-tumor therapies such as temozolomide [140,141,142], radiation [143,144,145,146,147,148,149], and targeted therapies [150,151,152].